Astria Therapeutics Inc
NASDAQ:ATXS

Watchlist Manager
Astria Therapeutics Inc Logo
Astria Therapeutics Inc
NASDAQ:ATXS
Watchlist
Price: 12.47 USD -2.65%
Market Cap: 711.8m USD

Profitability Summary

Astria Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Astria Therapeutics Inc

Margins Comparison
Astria Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Astria Therapeutics Inc
NASDAQ:ATXS
703.7m USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
379B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.9B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.1B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.5B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.7B EUR
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Astria Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Astria Therapeutics Inc
NASDAQ:ATXS
703.7m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
379B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.9B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.1B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.5B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
41.7B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.3B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Astria Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate